LFTSF (LifeTech Scientific) PEG Ratio: N/A (As of Jun. 30, 2026)


LFTSF LifeTech Scientific Corp LFTSF
96 GF Score
Price $0.23
GF Value $0.36
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, LifeTech Scientific's PE Ratio without NRI is 46.70. LifeTech Scientific's 5-Year EBITDA growth rate is -7.70%. Therefore, LifeTech Scientific's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for LifeTech Scientific's PEG Ratio or its related term are showing as below:


During the past 13 years, LifeTech Scientific's highest PEG Ratio was 13.64. The lowest was 1.28. And the median was 2.95.


LFTSF's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.05
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


LifeTech Scientific  (OTCPK:LFTSF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


LifeTech Scientific PEG Ratio Related Terms


LifeTech Scientific PEG Ratio Historical Data

* Premium members only.

The historical data trend for LifeTech Scientific's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific PEG Ratio Chart

LifeTech Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 1.52 5.01 0.00 0.00

LifeTech Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 0.00 0.00 0.00 0.00

LFTSF vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, LifeTech Scientific's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's PEG Ratio distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's PEG Ratio falls into.


LFTSF
96GF Score
LifeTech Scientific Corp LFTSF
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeTech Scientific PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

LifeTech Scientific's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=46.7/-7.70
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is LifeTech Scientific (LFTSF) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.

Key valuation signals for LFTSF:

  • PEG Ratio: N/A
  • GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score

Get the complete analysis for LFTSF

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price
$0.36
GF Value